New Leaf Biopharma Opportunities Ii, L.P. is of Harpoon Therapeutics, Inc.. Currently has a direct ownership of 0 shares of HARP, which is worth approximately $0. The most recent transaction as insider was on Mar 11, 2024, when has been sold 10,000 shares (8.000% Series A Redeemable Preferred Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

New Leaf Biopharma Opportunities II, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 11 2024
SELL
Sale (or disposition) back to the issuer
-
10,000 Reduced 100.0%
0 8.000% Series A Redeem...
Mar 11 2024
SELL
Sale (or disposition) back to the issuer
-
1,463,386 Reduced 100.0%
0 Common Stock
Oct 25 2023
BUY
Open market or private purchase
-
1,372,000 Added 48.39%
1,463,386 Common Stock
NLB

New Leaf Biopharma Opportunities Ii, L.P.

New York, NY

Track Institutional and Insider Activities on HARP

Follow Harpoon Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HARP shares.

Notify only if

Insider Trading

Get notified when an Harpoon Therapeutics, Inc. insider buys or sells HARP shares.

Notify only if

News

Receive news related to Harpoon Therapeutics, Inc.

Track Activities on HARP